Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 15, 2010Developmental Medicine & Child NeurologyOpen Access

Systemic adverse events following botulinum toxin A therapy in children with cerebral palsy

View Full Paper
Ask AI
Bookmark
Share

Authors

KNKRISHANT NAIDUKSKatherine R. SmithMSMary Sheedy

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

NAIDU et al. (2010) studied this question.

synapsesocial.com/papers/6a8290cb8ddd99b9b5239db3https://doi.org/10.1111/j.1469-8749.2009.03583.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Analgesic effects of botulinum toxin A: a randomized, placebo‐controlled clinical trial2000 · 51 citations
  2. 2Botulinum toxin A versus fixed cast stretching for dynamic calf tightness in cerebral palsy1999 · 202 citations
  3. 3Management of Spasticity in Cerebral Palsy with Botulinum-A Toxin: Report of a Preliminary, Randomized, Double-Blind Trial1994 · 311 citations
  4. 4Single event multilevel botulinum toxin type A treatment and surgery: similarities and differences2001 · 64 citations
  5. 5Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy2000 · 244 citations